Heartbeam, Inc.

Greetings and welcome to the HeartBeam third quarter 2023 financial results conference call. At this time, all participants are in a listen only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded. Before we begin the formal presentation, I would like to remind everyone that statements made on the call and webcast may include predictions, estimates, and other information that may be considered forward-looking. While these forward-looking statements represent our current judgment on what the future holds, they are subject to risks and uncertainties that could cause actual results to deter materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect our opinions only as of the date of this presentation. Please keep in mind that we are not obligating ourselves to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. Throughout today's discussion, we will attempt to present some important factors relating to our business that may affect our predictions. You should also review our most recent Form 10-K and Form 10-Q for a more complete discussion of these factors and other risks, particularly under the heading Risk Factors. A press release detailing these results crossed our wires this afternoon, and it's available in the Investor Relations section of our company's website, hardwareinbeing.com. Your hosts today, Bronis Nav, Vadej, Chief Executive Officer and Founder, Rob Eno, President, and Rick Brownstein, Chief Financial Officer, will present results of operations for the third quarter, end of September 30, 2023. At this time, I will turn the call over to Harbin Chief Executive Officer, Paneslav Vadej. Please go ahead, Sam.

Thank you, Operator, and good afternoon, everyone. I'm pleased to welcome you to today's third quarter 2023 Financial Results Conference call. On today's call, we will be relating some very important updates about our business, our products, including a landmark peer-reviewed study publication and a significant enhanced HeartBeam team. We continue to make steady progress towards upcoming clinical and regulatory milestones. I'd like to give you a brief overview of HeartBeam and our technology for those of you who just joined for the first time, and as a reminder for those of you who are already familiar with us. It's really important to understand how our VECG technology is different from exactly more powerful than most common personal ECG technologies that are in the marketplace today. There are many ECG technologies offered to consumers in patients outside of a medical facility. You can see a couple of examples on this slide. These are not 12-lead ECGs. Instead, they are one-lead, three-lead, or six-lead. This is adequate for detecting many arrhythmias, but is not sufficient to detect a heart attack or complex arrhythmias. while there are complex, I'm sorry, while there are many 12 ECG, I'm so sorry. Basically, what I'd like to say is that a couple of ECG technologies that are out there today that are indicated for at-home use, but we do not believe that these are adequate

and easy to use for the consumer and patients to adopt it.